Breakthrough PBS listings to benefit thousands of Australians
Thousands of Australians living with schizophrenia, liver disease, lymphoma and anaphylaxis now have access to new treatments through new and amended listings on the Pharmaceutical Benefits Scheme (PBS). Australians with schizophrenia now have access to the antipsychotic Reagila® (cariprazine). It is expected that over 39,500 Australians will benefit from this new treatment option. Without…